Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results

Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients

Oncotarget ◽

10.18632/oncotarget.16313 ◽

2017 ◽

Vol 8 (24) ◽

pp. 38706-38716 ◽

Cited By ~ 11

Author(s):

Jiayi Wu ◽

Yan Fang ◽

Lin Lin ◽

Xiaochun Fei ◽

Weiqi Gao ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Early Breast Cancer ◽

Recurrence Score ◽

Distribution Patterns ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive

433 Recurrence Score (RS) and Treatment Decisions in Node-positive (N+), Estrogen Receptor-positive (ER+) Breast Cancer Patients in Israel

European Journal of Cancer ◽

10.1016/s0959-8049(12)70499-9 ◽

2012 ◽

Vol 48 ◽

pp. S173

Author(s):

S.M. Stemmer ◽

N. Lieberman ◽

N. Efrat ◽

D.B. Geffen ◽

M. Steiner ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Recurrence Score ◽

Treatment Decisions ◽

Breast Cancer Patients ◽

Node Positive ◽

Estrogen Receptor Positive

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

The Breast ◽

10.1016/s0960-9776(17)30297-7 ◽

2017 ◽

Vol 32 ◽

pp. S92-S93

Author(s):

A. Gasol Cudos ◽

S. Morales Murillo ◽

M.J. Panades Siurana ◽

F. Vilardell Villellas ◽

C. Canosa Morales ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrence Score ◽

Treatment Decisions ◽

Oncotype Dx ◽

Single Institution ◽

Node Positive ◽

P206 German multicentre decision impact study of Oncotype DX recurrence score (RS) on adjuvant treatment in estrogen receptor positive (ER+) node negative (N0) and node positive (N+) early breast cancer

The Breast ◽

10.1016/s0960-9776(11)70147-3 ◽

2011 ◽

Vol 20 ◽

pp. S46 ◽

Cited By ~ 3

Author(s):

J.-U. Blohmer ◽

T. Kühn ◽

M. Rezai ◽

S. Kümmel ◽

M. Warm ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Recurrence Score ◽

Oncotype Dx ◽

Impact Study ◽

Node Negative ◽

88. Validity of Oncotype Dx recurrence score in predicting recurrence in hormone receptor positive and node negative early breast cancer patients

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.094 ◽

2016 ◽

Vol 42 (9) ◽

pp. S103

Author(s):

A. Munir ◽

S. Udyashankar ◽

D. Thomas ◽

G. Dazeley ◽

A. Huws ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

Node Negative ◽

Hormone Receptor Positive ◽

The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition

Annals of Surgical Oncology ◽

10.1245/s10434-018-7068-3 ◽

2018 ◽

Vol 26 (5) ◽

pp. 1227-1235 ◽

Cited By ~ 9

Author(s):

Maoli Wang ◽

Kejin Wu ◽

Peng Zhang ◽

Mingdi Zhang ◽

Ang Ding ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Prognostic Significance ◽

Recurrence Score ◽

Oncotype Dx ◽

8Th Edition ◽

HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab

The Breast ◽

10.1016/j.breast.2020.10.002 ◽

2020 ◽

Vol 54 ◽

pp. 235-241 ◽

Cited By ~ 2

Author(s):

Shuai Li ◽

Jiayi Wu ◽

Ou Huang ◽

Jianrong He ◽

Li Zhu ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

High Risk ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Her2 Positivity

Prediction of recurrence with the Oncotype DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.11052 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 11052-11052 ◽

Cited By ~ 8

Author(s):

Frederique Madeleine Penault-Llorca ◽

Thomas Filleron ◽

Bernard Asselain ◽

Frederick L. Baehner ◽

Pierre Fumoleau ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

Node Positive ◽

Oncotype Dx Recurrence Score ◽

Positive Breast Cancer

Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations

Breast Cancer Research and Treatment ◽

10.1007/s10549-016-3836-6 ◽

2016 ◽

Vol 157 (3) ◽

pp. 511-516 ◽

Cited By ~ 12

Author(s):

R. Lewin ◽

A. Sulkes ◽

T. Shochat ◽

D. Tsoref ◽

S. Rizel ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

Score Distribution ◽

Impact of the 21-gene Recurrence Score assay on the treatment of estrogen receptor-positive, HER2-negative, breast cancer patients with 1-3 positive nodes: A prospective clinical utility study

Clinical Breast Cancer ◽

10.1016/j.clbc.2021.09.004 ◽

2021 ◽

Author(s):

Nathalie LeVasseur ◽

Julia Sun ◽

David Fenton ◽

Simon Baxter ◽

Angela Chan ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Clinical Utility ◽

Recurrence Score ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive